Boston scientific initiates trial to evaluate industry's first modular crm system

Marlborough, mass., dec. 2, 2021 /prnewswire/ -- boston scientific corporation (nyse: bsx) has initiated the modular atp clinical trial to evaluate the safety, performance and effectiveness of the mcrm™ modular therapy system.
BSX Ratings Summary
BSX Quant Ranking